Broccoli D, Young J W, de Lange T
Laboratory for Cell Biology and Genetics, Rockefeller University, New York, NY 10021, USA.
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9082-6. doi: 10.1073/pnas.92.20.9082.
Bone marrow and peripheral blood leukocytes from 19 leukemia patients were found to contain telomerase activity detectable by a PCR-based assay. Telomerase was also detectable in nonmalignant bone marrow and peripheral blood leukocytes from normal donors, including fractions enriched for granulocytes, T lymphocytes, and monocytes/B cells. Semiquantitative comparison revealed considerable overlap between telomerase activities in samples from normal subjects and leukemia patients, confounding evaluation of the role of telomerase in this disease. These data indicate that human telomerase is not restricted to immortal cells and suggest that the somatic expression of this enzyme may be more widespread than was previously inferred from the decline of human telomeres.
通过基于聚合酶链反应(PCR)的检测方法发现,19例白血病患者的骨髓和外周血白细胞含有可检测到的端粒酶活性。在正常供体的非恶性骨髓和外周血白细胞中也可检测到端粒酶,包括富含粒细胞、T淋巴细胞和单核细胞/B细胞的组分。半定量比较显示,正常受试者和白血病患者样本中端粒酶活性有相当大的重叠,这使得对端粒酶在该疾病中作用的评估变得复杂。这些数据表明,人类端粒酶并不局限于永生细胞,提示该酶的体细胞表达可能比以前根据人类端粒缩短所推断的更为广泛。